Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Halozyme Therapeutics Inc. Common Stock (HALO) vs SK Hynix (SKHY) Price & Performance

Halozyme Therapeutics Inc. Common StockTrade

Price performance (Past 24H)

Key statistics

Halozyme Therapeutics Inc. Common Stock vs SK Hynix — how do they compare? Halozyme Therapeutics Inc. Common Stock trades at $110.59 (market cap $12.58B), while SK Hynix trades at $169.76 (market cap $891.31B). The key difference: SK Hynix is far larger — about 70.9× Halozyme Therapeutics Inc. Common Stock's market cap, and SK Hynix pays a 0.06% dividend while Halozyme Therapeutics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Halozyme Therapeutics Inc. Common Stock for 1 Days and SK Hynix for 10 Days on average.

HALOSKHY
Market Cap
$12.58B$891.31B
Volume
2,179,27822,268,296
Sector
HealthTechnology
52-Week High
$115.22$198.63
52-Week Low
$61.63$126.79
Typical Hold Time
1 Days10 Days
Enterprise Value
$14.49B$841.45B
Dividend Yield
—0.06%

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

HALO

No sentiment data available yet.

SKHY
79% Buy21% Sell
Avg holding period · 10 Days

Top news

Latest headlines on both assets

About Halozyme Therapeutics Inc. Common Stock

Halozyme Therapeutics develops drug-delivery technologies for biopharmaceutical companies. Its ENHANZE technology uses the rHuPH20 enzyme to support subcutaneous delivery of co-administered medicines.

Read more on HALO →

About SK Hynix

SK hynix is a South Korean semiconductor company that manufactures memory products, including DRAM and NAND flash. Its high-bandwidth memory (HBM) products are designed for high-performance computing and AI applications.

Read more on SKHY →